Widespread dispersal of progeny is expected to result in enough gene flow to maintain genetic homogeneity over large areas. Surveys of genetic markers in species with planktonic larvae have mostly confirmed this expectation. However, genetic structure has occasionally been found at small spatiotemporal scales and interpreted as evidence of restricted dispersal, natal homing, sweepstakes reproductive success, or natural selection. We investigated genetic population structure in blue crabs from the Atlantic and Gulf of Mexico coasts of North America. Sampling was most intensive from five estuaries along the coast of Louisiana, with megalopae, juveniles and adults sampled from 2010 to 2016. 1446 individuals were genotyped at 2486 SNPs in 1363 putative protein-coding loci. Levels of differentiation between locations were consistently low, but significant differentiation was found among locations and among years. No evidence was found for chaotic genetic patchiness or sweepstakes reproductive success: no genetic differentiation was detected among collections of megalopae and none of the sampled individuals were closely related. Our results indicate that gene flow in blue crabs maintains near genetic homogeneity from the northern Gulf of Mexico through the Atlantic coast of North America.

Background and purpose: Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome- Coronavirus 2 (SARS-CoV2) is a highly contagious disease that has infected more than 200,000 patients and led to more than 10000 deaths in 166 countries in less than four months. New medications are needed to combat this disease. Since the process of discovery, development and approval of new drugs is long, old drugs can be repurposed for treatment of COVID-19. Oseltamivir is used for management of COVID-19 and Influenza A. Rimantadine is an alternative drug to oseltamivir for management of influenza A. Therefore, it is possible that rimantadine can be used for management of COVID-19 as an alternative to oseltamivir. The purpose of the study is to verify the potential of rimantadine as a drug for COVID-19 Methods: The SARS-CoV2 nucleocapsid was downloaded from the Protein databank and the chemical structure of rimantadine downloaded from Pubchem. Molecular docking of the nucleocapsid as the receptor and rimantadine as the ligand was done using avogadro and chimera software. Prediction of pharmacokinetic properties was done using SWISSADME website while the toxicity properties predicted using the ProTox server. Results: The interactions between rimantadine and the SARS-CoV2 nucleocapsid involved conventional hydrogen bonding with threonine & asparagine; attractive charge interaction with aspartate and Pi-alkyl interaction with tryptophan. Rimantadine has high gastrointestinal activity, very few drug-drug interactions and is relatively safe. Conclusion: Rimantadine binds to the SARS-CoV2 nucleocapsid and can thus be used for management of COVID-19. Keywords: Rimantadine, COVID-19, SARS-CoV2, Oseltamivir

Abstract: In this paper the feeding index (FI), Gastro somatic index (GaSI) and Food Prevalence Index (FPI) of freshwater prawn M. assamense peninsulare were evaluated to assess the quantity and kind of food which this prawn consumes in the Rawasan stream. A total of 401 prawns were collected for an interval of two years form five selected site in Rawasan stream of Garhwal in Central Himalaya, India from August 2013 to July 2015. Collected prawn was in the size range of 20-75 mm in male and 24-65 mm in female in total length during the study period. The stomach contents of 10 collected specimens were examined monthly and observed that 35% of the stomach was full or semi-full and 15% stomach were empty. Highest Gastro somatic value (Mean±SE) was obtained 2.95±0.80 during June in the male and 3.25±0.44 during May in the female. After that, it gradually decreased in both the sex and this repeated in cyclic pattern each year. More or less a similar trend was reported in the feeding index value during the study indicate a significant relationship between feeding intensity and Gastro somatic index. Highest Food Prevalence Index (FPI) was seen in fragment of animals in both sex, which was (88.48) in male and (58.26) in female prawn and lowest FPI value in sand debris 7.9 and 5.7 in male & female prawn respectively. Main food items were fragment of plants & animal, diatoms, algae, and sand. In overall, the results show that this prawn is selectively abstemious

Abstract Rationale, aims and objectives: Sri Lanka has a well-established government-funded universal health coverage which provides free health care to all citizens. The aim of this qualitative study was to examine the out-of-pocket expenses incurred by patients with cirrhosis during admission to a tertiary care government hospital in Sri Lanka, and the impact such expenses might have on equity of care and patient outcome. Methods This is a qualitative study conducted among patients with cirrhosis admitted to a tertiary-care hospital, their caregivers and physicians. Quota sampling was used until data saturation was achieved. Data was collected through individual interviews and small group discussions using directed and open-ended questions. Thematic framework method was used to analyze data. Out-of-pocket expenses incurred by patients, its impact on equity of patient care and outcome were investigated. Results Costs for laboratory investigations, drugs purchased from the private sector and hired caretakers for hospitalized patients were reported as direct expenses. Loss of work and other sources of income were the primary indirect expenses. The impact of such expenses was higher in patients and families from lower socioeconomic categories, especially among those who were dependent on a daily income. Health care workers actively tried to minimize these out-of-pocket expenses, resulting in choice on investigations, drugs and other interventions often being made by the clinician and occasionally not being discussed with the patient, resulting in poor patient satisfaction. Conclusion This study reveals a substantial direct and indirect economic impact on patients despite being cared for in a government hospital with universal health coverage. The impact was more in patients from lower socioeconomic strata, potentially resulting in inequity in the care provided as well as the health outcomes.

Title:Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).Running title:Ondansetron in pregnancyPer DamkierMD, PhDDepartment of Clinical Biochemistry & Pharmacology Odense University Hospital, DenmarkDepartment of Clinical research University of Southern Denmark, DenmarkMail:[email protected]: +45 65 50 37 90Ondansetron is an effective antiemetic that is being widely used as a second-line treatment option for severe Nausea and Vomiting of Pregnancy (NVP) in accordance with clinical guidelines (1–4).In July 2019, the European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) released updated comprehensive assessment report on the use of ondansetron in first trimester (5). This report is a detailed assessment of the available published data on the subject, including responses to supplementary questions posed to the Marking Authorization Holder (MAH), and the authors to the two central publications discussed below. The ensuing Summary of product Characteristics (SmPC) was updated in November 2019 with important changes to section 4.6 “Fertility, pregnancy and lactation” (6), which now state that ondansetron should not be used in first trimester of pregnancy.We acknowledge that the EMA SmPC in principal only frames the way that the MAH are legally allowed to market their product within the EU. It does not bind the physician as such; they must act and adhere with reference to the legal framework of their respective countries. We also acknowledge that EMA operates within a given formalized set of options on SmPC phrasings. In everyday practice however, the wording of the SmPC has consequences for treatment options and decision support beyond those formal to the legal ramifications of the SmPC.We applaud the EMA for the following nuanced phrasings in the SmPC:Based on human experience from epidemiological studies, ondansetron is suspected to cause orofacial malformations when administered during the first trimester of pregnancy.In one cohort study including 1.8 million pregnancies, first trimester ondansetron use was associated with an increased risk of oral clefts (3 additional cases per 10 000 women treated; adjusted relative risk, 1.24, (95% CI 1.03-1.48)).The available epidemiological studies on cardiac malformations show conflicting results. We believe that data from animal studies are of less relevance in these and analogue situations with an abundance of human data available:“Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity.”We do not believe that the most important sentence therein is appropriately substantiated or justified:“Ondansetron should not be used during the first trimester of pregnancy.”The latter statement comes with very clear and immediate consequences to clinical practice and pregnant women suffering from NVP. Previous somewhat contradictory data notwithstanding (7), the core of the discussion is down to the interpretation of two extraordinarily large sets of data. These are recent publications each comprising 80.000+ first-trimester exposed liveborn children. Previous studies with somewhat contradictory results comprise cumulated first trimester exposures less than 10% of these new data.Huybrechts et al., a well-established research group within studies of adverse pregnancy outcome following drug exposure during pregnancy with an elite publication track-record, published their large study in December 2018 (8). In this meticulously designed, conducted and reported study comprising 88.000 liveborn children exposed to ondansetron in first trimester, they reported no increased overall risk of malformations and null associations for any or cardiac malformations and a small increased risk for oral cleft. Compared to 1,727.000 unexposed liveborn, propensity score adjusted relative risks were 1.01 (95% CI 0.98-1.05), 0.99 (95% CI 0.93-1.06) and 1.24 (95% CI 1.03-1.48) for any, cardiac and oral cleft malformations, respectively. The increased risk of oral clefts corresponds to about 3 additional cases for every 10.000-liveborn children exposed to ondansetron in first trimester.Zambelli-Weiner et al. published their findings from a large study in January 2019 (9). This triggered controversy and extensive discussions among clinicians and researchers within the field.They reported data on 82.000 liveborn children exposed to ondansetron in first trimester. Compared to about 780.000 unexposed liveborn, their overall analysis identified a weak but no clinically meaningful association with cardiac effects, aOR 1.04 (95% CI 1.00-1.08) and a weak association to orofacial clefts, aOR 1.12 (95% CI: 0.95-1.33). Ade facto subgroup analysis – defined by the authors as “primary analysis” - restricted exposure to 5.500 women who were administered ondansetron in hospitals (“medical administration”). The inferential analysis substantially reinforced the overall weak signal for cardiac effects (aOR 1.43; 95% CI 1.28-1.61) but not orofacial clefts, (aOR 1.30; 95% CI: 0.75-2.25). The technical analysis appears suboptimal as adjustments were made as by a crude approach; i.e. the selection of confounder variables was based on these resulting in at least 10% change in effect estimates rather than simply including all selected confounders in the model.It appears plausible that this subpopulation of pregnant women in whom hospital treatment was deemed necessary, suffered from a more severe presentation of NVP, a confounder that they did not accounted for. The sensitivity analysis performed in patients assigned a diagnosis of NVP or hyperemesis gravidarum does not satisfactorily account for this. In almost all exposed cases, the exposure comprised a single intravenous dose of ondansetron. It is biologically counterintuitive that a causal relation to cardiac malformations be present based on such exposure. The paper reports extraordinarily high rates of congenital cardiac malformations be it among unexposed (3.7%) or exposed (5.5 and 4.1% for intravenous and any exposure, respectively) liveborn children. These observations are incompatible with all other reported data on the rate of congenital cardiac malformations. The external validity of the study findings is therefore less convincing and compromises comparisons to other findings.The authors did not provide satisfactory responses to additional questions poses by PRAC during the assessment process. Five specific questions were posed, and the authors did not address any of these. They provided a short narrative statement that did not serve to clarify or advance understanding of their findings (5). Not least, this paper is severely compromised by an initially undisclosed serious conflict of interest. The formal COI disclosure in the paper state: ”As an organization, TTi reports receiving funds from plaintiff law firms involved in ondansetron litigation…” The extent of this COI was only revealed during a litigation process. The specific study received substantial funding ($ 210.000) from plaintiffs’ representation who was pursuing litigative damage by claiming malformations from ondansetron use in pregnancy (10). It is the position of the undersigned and ENTIS Scientific Committee that this study is methodologically and ethically compromised to an extent that the results thereof cannot be considered when assessing the totality of evidence on the safety of ondansetron in pregnancy.Since the PRAC recommendation two additional studies have been published that should be considered in the overall assessment of the risk during pregnancy.In January 2020, Huybrechts et al. published an additional study on intravenous administration of ondansetron in early pregnancy and risk of congenital malformations (11). In this study, the authors revisited the study population from their original paper, but restricted their analysis to those women who received intravenous ondansetron in first trimester (8). The resulting propensity-score adjusted inferential analysis of about 24.000 pregnancies exposed to intravenous ondansetron did not result in increased risk of cardiac malformations (RR 0.97; 95% CI 0.86-1.10), oral clefts (RR 0.95; 95% CI 0.63-1.43), or any congenital malformation(RR 1.02; 95% CI 0.96-1.08). Unadjusted analyses suggested a small increased risk for cardiac and any malformation (11). These data strongly mitigate the previous data on intravenous ondansetron (9).Lemon and colleagues reported a small increased risk of ventricular septal defect (VSD) following first trimester exposure to intravenous or oral ondansetron in first trimester among 3700 pregnancies (12). Across various methodological approaches the adjusted risk ratio varied between 1.7 and 2.1 with 95% CI ranging between 1.0 and 4.0. In an overall analysis though there was no increased risk for any birth defect or any heart defect, illustrating the dilemma of splitting versus lumping in such analyses (13). In this study, there may be an issue of ascertainment bias. Women exposed to ondansetron likely suffered from more severe NVP and thus may have been be subject to more attention and their newborn babies to a greater extent are subject to an echocardiograph evaluation. VSDs may be clinically asymptomatic and ”Up to 80% of small, muscular VSDs and 30%-50% of perimembranous defects will close spontaneously” (14).In summary, we believe that the abundance of most methodologically convincing data on cardiovascular malformations is reasonably reassuring. Even if a small excess risk may still be present, ondansetron in first trimester should remain an option for pregnant women with severe NVP.It is the opinion of ENTIS that the EMA decision to explicitly discourage first trimester treatment with ondansetron puts pregnant women with severe NVP, physicians and health care professionals between a rock and a hard place. We do not agree that the specific wording against the use of ondansetron in first trimester is justified and we do not support the conclusion of EMA/PRAC assessment report and this section of the SmPC.We urge the EMA/PRAC to carefully consider everyday clinical consequences of formal regulatory decisions. In cases with likely widespread clinical consequences, we suggest that EMA/PRAC consult liberally with relevant patient organizations, clinicians and health care professionals before final adoption of a recommendation.

1. Gummosis on Acacia decurrens, an invasive tree species, that got established in Merapi Volcano National Park (MVNP) after the eruption of Mount Merapi in 2010 was studied to i) identify the causal organism of the disease, ii) analyze disease symptoms, iii) understand the spatio-temporal distribution of gummosis in the tree population and iv) examine how the disease affects the anatomy of tree wood. 2. Pathological, morphological and molecular studies were used in this studies. 3. Ceratocystis fimbriata was proved to be the causal organism of the disease. The disease spread was probably aided by the ambrosia beetle (Euwallacea sp.) which bores holes on the stem. 4. The disease is noted to spread from the base of the trees, where the ambrosia beetle bores holes first, to the upper part. 5. The number of parenchyma cells in the infected stem was significantly more than in the healthy stem which apparently facilitated water and nutrition transport within the tree helping it to grow normally despite serious gummosis. 6. The management of invasion by A. decurrens in the MVNP area poses a serious challenge due its success as an invader in the volcano impacted area and the threat of the gummosis pathogen spreading to other species both of which will affect the regeneration and establishment of native species and recuperation of the ecosystem.

We have recently developed a computational methodology to separate the effects of size, composition, symmetry and fluxionality in explaining the experimental photoelectron spectra of mixed-metal clusters. This methodology was successfully applied first in explaining the observed differences between the spectra of Al13- and Al12Ni- and more recently to explain the measured spectra of AlnMo-, n=3-5,7 clusters. The combination of our approach and new synthesis techniques can be used to prepare cluster based materials with tunable properties. In this work we use the methodology to predict the spectrum of Al6Mo-. This system was chosen because its neutral counterpart is a perfect octahedron and it is distorted to a D3d symmetry and was not observed in the recent experiments. This high symmetry cluster bridges the less symmetric Al5Mo- and Al7Mo-structures. The measured spectra of Al5Mo- has well defined peaks, while that of Al7Mo-does not. This can be explained by the fluxionality of Al7Mo-, as at least 6 different structures lie within the range that can be reached by thermal effects. We predict that Al6Mo- has well defined peaks, but some broadening is expected as there are two low-lying isomers, one of D3d and the second of D3h symmetry that are only 0.052 eV apart.

Due to low working temperature, high energy density and low pollution, proton exchange fuel cells have been investigated under different operating conditions in different applications. Using platinum catalysts in methanol fuel cells leads to increasing the cost of this kind of fuel cell which is considered as a barrier to the commercialism of this technology. For this reason, a lot of efforts have been made to reduce the loading of the catalyst required on different supports. In this study, carbon black (CB) and carbon nanotubes (CNT) have been used as catalyst supports of the fuel cell as well as using the double-metal combination of platinum-ruthenium (PtRu) as anode electrode catalyst and platinum (Pt) as cathode electrode catalyst. The performance of these two types of electro-catalyst in the oxidation reaction of methanol has been compared based on electrochemical tests. Results showed that the carbon nanotubes increase the performance of the micro-fuel cell by 37% at maximum power density, compared to the carbon black.Based on thee-electrode tests of chronoamperometry and voltammetry, it was found that the oxidation onset potential of methanol for CNT has been around 20% less than CB, leading to the kinetic improvement of the oxidation reaction.The current density of methanol oxidation reaction increased up to 62% in CNT sample compared to CB supported one, therefore the active electrochemical surface area of the catalyst has been increased up to 90% by using CNT compared to CB which shows the significant rise of the electrocatalytic activity in CNT supported catalyst.

Machine learning techniques have been successfully used to simulate and optimise bioprocesses. This study explores the feasibility to apply Gradient Boosting, an emerging Ensemble Learning algorithm, which combines weak learners to generate better predictions for bioprocess dynamic modelling and prediction. A thorough procedure was presented for Gradient Boosting based data-driven model construction. Different case studies were employed including fermentation and algal photo-production processes. Given that generating a large size of experimental data for model training is time consuming and challenging to many bioprocesses, this work launched a first investigation on the data efficiency of Gradient Boosting by comparing its predictive capability against the predominantly used artificial neural networks. By carrying out a series of experimental verifications over a broad spectrum of process operating conditions, this study concluded that Gradient Boosting may have several advantages in small experimental datasets and can outperform artificial neural networks for bioprocess predictive modelling, indicating its potential for future bioprocess digitalisation and optimisation.

Anticoagulants are used in the treatment and prevention of thromboembolism. The most common indications for long-term anticoagulation with warfarin are atrial fibrillation, mechanical heart valves and venous thromboembolism. A number of anticoagulants are available, including unfractioned heparin, low molecular weight heparin, and the vitamin K antagonists; warfarin, acenocoumarol and phenindione. These anticoagulants have been used for many years, and at present most people who require an anticoagulant are prescribed warfarin.However, recent national guidelines have recommended the use of New oral anticoagulants(NOAC) in certain circumstances. The new oral anticoagulants; rivaroxaban, dabigatran and apixaban have all completed phase III clinical trials for stroke prevention in patients with atrial fibrillation, and many countries, including the United Kingdom, have approved the use of the new oral anticoagulants for the prevention of cerebrovascular accidents and systemic embolism in patients with atrial fibrillation and the treatment and prevention of deep vein thrombosis and pulmonary embolism.This report aims to look at the peri-operative management of patient using the NOACs.

The study analyzes the Italian Novel Coronavirus (2019-nCov) outbreaks, searching possible predicting model, underlining the risk of the Trend of phenomena.

Atherosclerosis is considered a systemic disease, and its presence in any site of the arterial system in the body raises suspicion of its presence somewhere else. Since atherothrombosis represents the most common cause of stroke, it is important to investigate whether coronary artery calcification, a commonly used measure of cardiac atherosclerotic burden, can be a similarly useful measure of atherosclerotic burden in the brain. This review aimed to summarize the current evidence regarding the role of CAC in the detection and prevention of cerebrovascular disease. CAC is an independent risk factor of stroke development, and using it to supplement traditional risk factors may allow better identification of higher-risk groups. Intermediate risk patients with elevated CAC scores can be started on statin therapy. CAC score may hold promise in identifying patient groups most likely to benefit from aspirin therapy. In addition, it may have a role in the identification of stroke patients who may benefit from closer cardiac monitoring as it can aid traditional scores in the detection of coronary pathology in stroke survivors.

DNA barcoding identification needs a good characterization of intra-specific genetic divergence to establish the limits between species. Yet, the number of barcodes per species is many times low and geographically restricted. A poor coverage of the species distribution range may hamper identification, especially when undersampled areas host genetically distinct lineages. If so, the genetic distance between some query sequences and reference barcodes may exceed the maximum intra-specific threshold for unequivocal species assignation. Taking a group of Quercus herbivores (moths) in Europe as model system, we found that the number of DNA barcodes from southern Europe is proportionally very low in the Barcoding of Life Data Systems (BOLD). This geographical bias complicates the identification of southern query sequences, due to their high intra-specific genetic distance with respect to barcodes from higher latitudes. Pairwise intra-specific genetic divergence increased along with spatial distance, but was higher when at least one of the sampling sites was in southern Europe. Accordingly, GMYC (General Mixed Yule Coalescent) single threshold model retrieved clusters constituted exclusively by Iberian haplotypes, some of which could correspond to cryptic species. The number of putative species retrieved was more reliable than that of multiple threshold GMYC but very similar to results from ABGD and jMOTU. Our results support GMYC as a key resource for species delimitation within poorly inventoried biogeographic regions in Europe, where historical factors (e.g. glaciations) have promoted genetic diversity and singularity. Future European DNA barcoding initiatives should be preferentially performed along latitudinal gradients, with special focus on southern peninsulas.

1. The abundance of UV-B absorbing compounds (for example p-Coumaric acid, pCA) within pollen-grain sporopollenin has been proposed as a proxy for reconstructing past changes in surface solar radiation, but drivers of the variation of these compounds in pollen grains remains poorly understood. 2. One important consideration is that the physiological response that results in the production and timing of pCA in pollen remains poorly understood. This calls for studies that explicitly tests the temporal resolution and plasticity of the response of pCA in pollen under field conditions. 3. To address this, we conducted two parallel experiments. First, we measured pCA in four Pinus spp. from Geneva in two consecutive years to investigate the impact of natural variation in ambient solar radiation, and differences in responses between species. Second, we covered pollen cones on Pinus sylvestris trees in Bergen with 90% shading cloth one month before dehiscence and compared the amount of pCA in pollen from shaded and sun-exposed cones from the same tree. 4. Between years, in Geneva, Pinus spp. produced 31% more pCA in 2014 than in 2013, with higher levels of solar radiation also observed in 2014. pCA content also showed strong species-level variation, largely reflecting differences in pollen size between species. Experimentally shaded Pinus sylvestris pollen produced 21% less pCA than fully exposed pollen. 5. Our work demonstrates a plastic response in the production of UV absorbing compounds (pCA) to inter-annual and experimentally induced variation in ambient solar radiation in Pinus spp. pollen. This supports pCA as a highly responsive proxy for early-season solar radiation. We also find strong species-level variation in pCA content in pine pollen, likely related to pollen grain size, which should be accounted for in reconstructions from sites with multiple Pinus species present.

Etherification mechanism of 4,5-dihydroxy-1,3-bis (hydroxymethyl) imidazolidin-2-one (DMDHEU) with the primary alcohols and the –OH hydroxyl groups of cellulose chain (n=1-2) in acidic condition were investigated by using density functional theory (DFT) method and a two-layer ONIOM approach. Geometry and energy of reactants, products, intermediate complexes, carbocation intermediate, and transition states were optimized at B3LYP/6-311g(d,p) level and ONIOM (B3LYP/6-311g(d,p):PM3MM) level. Computational results indicate that the etherification adheres to unimolecular nucleophilic substitution (SN1) mechanism; the reactant and product can form the activated complexes with H+ ions in which H+ ions are occupied by the O-atom of C=O group in the reactant complex and the product complex. Potential energy surface (PES) of the reaction has the triple-well shape. Effect of substituent R in primary alcohol R-CH2OH (R = H, CH3, CH2CH3, CH2OCH3, CH2F) and cellulose chain on the reactivity is significant. The energy barrier of H+ ions releasing step is much higher than those of the activation steps. The calculational data is in the good agreement with the experimental data in the literature.

Plant negative density dependence is the result of interactions between plants themselves and between plants and the environment. We selected a succession series comprising early successional, mid-successional and late successional stages (Artemisia ordosica, Sophora alopecuroides and Stipa bungeana communities, respectively) in a semi-arid area. We investigated plant density and biomass and determined the nitrogen (N) and phosphorus (P) contents of each plant species in each of 225 quadrats, and we calculated the N and P contents of vegetation using biomass as a weighted coefficient. We found that the total plant density of the A. ordosica community increased with the increase in vegetation N:P ratio while the total plant density of the S. bungeana community decreased with the increase in vegetation N:P ratio, with the latter (late successional stage) community exhibiting negative density dependence. In the communities representing the early successional and mid-successional stages, the vertex coordinate of the quadratic function relationship between plant total density and vegetation N/P ratio was (16.6, 353.3); that is, if the N:P ratio of the vegetation was greater than 16.6, the community was characterized by negative density dependence. The analysis showed that the negative density dependence was due to P limitation. These findings reveal that the vegetation N:P ratio in a semi-arid region is the driver of negative density dependence.

The Arctic pelagic environment is expected to strongly alter due to global climate change. As a consequence, modification of the unicellular plankton species composition and biomass, with consequences to biogeochemical cycling and pelagic food web, is expected. In this study we used meta-barcoding of the V4 region of the 18S rRNA gene to profile eukaryotic microbial communities exported to deeper water layers at the Long-Term Ecological Research Site HAUSGARTEN in the northeastern Fram Strait. We collected sinking particles at ca. 80 to 300 m depths using long-term deployed sediment traps and analyzed selected samples of spring and summer periods from 2000-2011. Acknowledging the limitations and biases of currently used 18S rRNA gene meta-barcoding primers in detecting certain taxa especially from environmental samples, we developed new primer sets and compared them with those already in use. Using the information generated by three different primer sets, the results of our study suggest decreasing trends in the abundances of large-cell phytoplankton (i.e., diatoms) and increasing pico-phytoplankton (Micromonas sp. and haptophytes) during the warm anomaly of 2005-2007. Phylogenetic analyses further revealed the displacement of cold-adapted with warm-adapted phylotypes of Micromonas and haptophytes, which could be related to the warming event. Ecotype-level changes observed in this study do not only suggest changing structures in community composition and ecosystem functioning but also in the biogeography and distribution of some species. These data provided new insights and information on the potential diversity changes and species displacement brought about by the environmental changes occurring in the Arctic Ocean.

The shifting defence hypothesis attributes the invasion success of many plant species to the species’ post- introduction evolution of traits that confer high fitness including reduced allocation to physiologically and ecologically costly chemical defence compounds against herbivores. However, to date, most of the studies that compared invasive and conspecific native plants for differences in defence compounds focused only on one or a few compounds. Thus, it remains unclear whether invasive plants may evolve a lower diversity of defence compounds in response to a simplified herbivore community assemblages in the introduced range. Therefore, the present study used B. nigra plants from 11 invasive- and 14 native range populations to test whether invasive B. nigra plants: i) express a lower diversity of glucosinolate compounds and higher concentration of a single dominant glucosinolate compound owing to a reduced diversity of herbivores in the introduced range; ii) are less preferred by generalist herbivores and attract more specialist herbivore species than B. nigra from the native range when grown in a common garden in the native range; iii) are less preferred by generalist herbivores than native-range B. nigra in no- choice feeding bioassays. In support of the shifting defence hypothesis, invasive B. nigra plants expressed a lower diversity of glucosinolates and a higher concentration of sinigrin (a major glucosinolate compound in B. nigra) than native-range B. nigra plants. Moreover, the invasive B. nigra plants were more deterrent to two generalist herbivore species in no-choice feeding bioassays than native B. nigra plants. Brassica nigra plants that expressed higher concentrations and diversities of glucosinolate compounds were visited by a more diverse specialist herbivore community than B. nigra plants with low concentrations and diversities of glucosinolates. The biogeographical differences in glucosinolate profiles observed here may be the result of differential herbivore selection pressures in the respective invaded and native ranges.